Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-d-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer

European Journal of Cardio-thoracic Surgery

Volumn 42, Issue 1, 2012, Pages 89-92

  Ose, Naoko ^a,b   Sawabata, Noriyoshi ^a   Minami, Masato ^a   Inoue, Masayoshi ^a   Shintani, Yasushi ^a   Kadota, Yoshihisa ^c   Okumura, Meinoshin ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TONEYAMA NATIONAL HOSPITAL   (Japan)

^c OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

Author keywords

FGD PET CT; Lung cancer; Lymph node metastasis; Pathological diagnosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; LARGE CELL CARCINOMA; LEUKOCYTE COUNT; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SMOKING; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; COMPUTER ASSISTED EMISSION TOMOGRAPHY; EVALUATION; LABORATORY DIAGNOSIS; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREOPERATIVE CARE; RETROSPECTIVE STUDY; SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84871689491     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezr287     Document Type: Article

References (16)

1. wamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Matastases from nonsmall cell lung cancer: mediastinal staging in the 1990s-meta-analytic comparison of PET and CT. Radiology 1999;213:530-6.
2. Bakheet SM, Powe J. Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med 1998;28:352-8.
3. Roberts PF, Follette DM, von Haag D, Park JA, Valk PE, Pounds TR et al. Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg 2000;70:1154-60.
4. Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 2003;229:526-33.
5. Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 2005;236:1011-9.
6. Yang W, Fu Z, Yu J, Yuan S, Zhang B, Li D et al. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer. Lung cancer 2008;61:35-43.
7. Kubota K. From tumor biology to clinical Pet: a review of positron emission tomography (PET) in oncology. Ann Nucl Med 2001;15: 471-86.
8. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972-80.
9. Shiraki N, Hara M, Ogino H, Shibamoto Y, Iida A, Tamaki T et al. False-positive and true-negative hilar and mediastinal lymph nodes on FDG-PET-radiological-pathological correlation. Ann Nucl Med 2004;18:23-8.
10. Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. The size of metastatic foci and lymph nodes yielding false-negative and falsepositive lymph node staging with positron emission tomography in patients with lung cancer. J Thorac Cardiovasc Surg 2004;127: 1087-92.
11. Konishi J, Yamazaki K, Tsukamoto E, Tamaki N, Onodera Y, Otake T et al. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration 2003;70:500-6.
12. Higashi K, Ueda Y, Ayabe K, Sakurai A, Seki H, Nambu Y et al. FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features. Nucl Med Commun 2000;21: 707-14.
13. Kenji N, Yukitoshi S, Yoshio M, Sakae O, Ken N, Yuichi I. A case of FDG-PET positive lung cancer with hilar lymph node metastases, which showed false negative FDG-PET findings. JJLC 2005;45:381-6.
14. Tsubamoto M, Kuriyama J, Kido S, Arisawa J, Kohno N, Johkoh T et al. Detection of lung cancer on chest radiographs: analysis on the basis of size and extent of ground glass opacity at the thin-section CT. Radiology 2002;224:139-44.
15. Ozawa Y, Hara M, Sakurai K, Nakagawa M, Tamaki T, Nishio M et al. Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer. Acta Radiol 2010;51:150-5.
16. Vesselle H, Pugsley JM, Vallieres E, Wood DE. The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer. J Thorac Cardiovasc Surg 2002; 124:511-9.